Searched for
CIPLA STOCK UPDATE
Pharma stocks in focus after medicine tariff changes in Union Budget 2025Finance Minister Sitharaman announced the inclusion of six life-saving drugs in the concessional 5% duty slab to enhance access to critical...- Cipla Q3 preview: Up to 7% YoY uptick seen in revenue. Margins to fall on a YoY and sequential basisCipla's Q3FY25 revenue is expected to grow 3.1-7%, with profit estimates ranging from a 2.2% decline to 14% growth. Brokerages have differi...
- Cipla Q2 Results: PAT rises 15% YoY to Rs 1,303 crore, beats estimatesCipla Q2 Results: Revenue from operations increased 6% year-on-year to Rs 7,051 crore in July-September 2024, up from Rs 6,678 crore in the...
- Cipla Q1 Results: Cons PAT rises 18% YoY to Rs 1,178 crore, beats estimatesCipla Q1 Results: The profit beat the ET Now Poll estimates of Rs 1,071 crore. Revenue from operations in the reporting period increased 6%...
- Cipla Q4 Results: Net profit jumps 79% YoY to Rs 939 crore on strong sales momentumCipla's North America sales, which constitute primarily US, grew 11.8% YoY to Rs 1875 crore driven by key products Lanreotide (used for tre...
- Balkrishna Industries, Dixon Technologies among 5 stocks with top short-coveringShort covering refers to the buying of shares in order to close an existing short position or a position that has been sold.
- Cipla slumps nearly 8% after USFDA warning letter for manufacturing lapsesAfter an inspection at the Pithampur plant, the USFDA issued a warning letter stating that the company's methods, facilities, or controls f...
- Cipla Q2 Results: Net profit jumps 45% YoY to Rs 1131 croreCipla's India business that contributes 42% to overall revenue grew 10% YoY to Rs 2817 crore in Q2FY24 with continued momentum across brand...
- Stock market update: Stocks that hit 52-week lows on NSE in today's tradeInfosys, Adani Ent., Cipla, Apollo Hospital and NTPC were among the top losers on NSE in today's trade.
- Stock market update: Stocks that hit 52-week lows on NSEHDFC Life, Infosys, Cipla, Apollo Hospital and NTPC were among the top losers on NSE.
- SBI Life, Cipla among 5 BSE 100 stocks which hit new 52-week high on TuesdayTuesday, August 08, 2023, marked a remarkable day for the BSE 100 index as several key stocks surged to new 52-week highs, underscoring str...
- Zomato, Cipla among 4 large cap stocks which hit new 52-week high on FridayThe data was sourced from BSE at 2.05 pm, and the updates from the real-time data could come with a lag. The below data also pertains only ...
- Brokerages see up to 20% upside in Cipla post Q1 results; time to buy?Cipla is on track to launch key products, such as gAdvair, gAbraxane, gRevlimid and three peptide products over FY23-24, it said, adding th...
- Cipla tanks 5% as promoters sell stake in block dealDr Y K Hamied, Chairman and MK Hamied, Vice Chairman who are Non-Executive Directors and promoters, have sold 2,01,69,756 shares, represent...
- Cipla gains on resolving funding dispute with US-based PulmatrixThe funding tussle with Pulmatrix Inc was regarding the development of Pulmazole, an asthma medication that is currently under development.
- Q4 earning preview: Pharma pack up for good show, may go unscathed from virus hitInvestors may keenly follow Sun Pharma earnings for updates on Halol OAI.
- Buy Cipla, target Rs 605: HDFC SecuritiesBuy Cipla at a price target of Rs 605.
- Mapping the market: Look who all gained when market shrugged off border turmoilLiquor stocks soared up to 20 per cent after the Supreme Court dismissed a BJP leader’s plea seeking a complete ban on liquor across India.
- Cipla Medpro likely to push India's Cipla to raise bidCipla Ltd is to offer 8.55 rand per share for a 51 percent stake in Cipla Medpro. The Indian group supplies drugs to the Cape Town-based co...
- Hold Cipla for target of Rs 252: KR ChokseyIn its results update on pharmaceutical major Cipla, brokerage KR Choksey has advised investors to Hold the stock for a price target of Rs ...
Load More
